Skip to main content

Detection of c-myc Amplification in Formalin-Fixed Paraffin-Embedded Tumor Tissue by Chromogenic In Situ Hybridization (CISH)

  • Protocol
  • First Online:
The Myc Gene

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1012))

Abstract

In situ hybridization (ISH) allows evaluation of genetic abnormalities, such as changes in chromosome number, chromosome translocations or gene amplifications, by hybridization of tagged DNA (or RNA) probes with complementary DNA (or RNA) sequences in interphase nuclei of target tissue. However, chromogenic in situ hybridization (CISH) is also applicable to formalin-fixed, paraffin-embedded (FFPE) tissues, besides metaphase chromosome spreads. CISH is similar to fluorescent in situ hybridization (FISH) regarding pretreatments and hybridization protocols but differs in the way of visualization. Indeed, CISH signal detection is similar to that used in immunohistochemistry, making use of a peroxidase-based chromogenic reaction instead of fluorescent dyes. In particular, tagged DNA probes are indirectly detected using an enzyme-conjugated antibody targeting the tags. The enzymatic reaction of the chromogenic substrate leads to the formation of strong permanent brown signals that can be visualized by bright-field microscopy at 40 × magnification. The advantage of CISH is that it allows the simultaneous observation of gene amplification and tissue morphology and the slides can be stored for a long time.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Deming SL, Nass SJ, Dickson RB, Trock BJ (2000) C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance. Br J Cancer 83:1688–1695

    Article  PubMed  CAS  Google Scholar 

  2. Masramon L, Arribas R, Tartola S, Perucho M, Peinado MA (1998) Moderate amplifications of the c-myc gene correlate with molecular and clinicopathological parameters in colorectal cancer. Br J Cancer 77:2349–2356

    Article  PubMed  CAS  Google Scholar 

  3. Augenlicht LH, Wadler S, Corner G, Richards C, Ryan L, Multani AS et al (1997) Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial. Cancer Res 57:1769

    PubMed  CAS  Google Scholar 

  4. Baker VV, Borst MP, Dixon D, Hatch KD, Shingleton HM, Miller D (1990) C-myc amplification in ovarian cancer. Gynecol Oncol 38:340–342

    Article  PubMed  CAS  Google Scholar 

  5. Mitani S, Kamata H, Fujiwara M, Aoki N, Tango T, Fukuchi K, Oka T (2001) Analysis of c-myc DNA amplification in non-small cell lung carcinoma in comparison with small cell lung carcinoma using polymerase chain reaction. Clin Exp Med 1:105–111

    Article  PubMed  CAS  Google Scholar 

  6. Rodriguez-Pinilla MS, Jones RL, Lambros MBK, Arriola E, Savage K, James M et al (2007) MYC amplification in breast cancer: a chromogenic in situ hybridisation study. J Clin Pathol 60:1017–1023

    Article  PubMed  Google Scholar 

  7. Todorović-Raković N, Nešković-Konstantinović Z, Nikolić-Vukosavljević D (2011) C-myc as a predictive marker for chemotherapy in metastatic breast cancer. Clin Exp Med DOI10.1007/s10238-011-0169-y

    Google Scholar 

  8. Hsi B-L, Xiao S, Fletcher JA (2002) Chromogenic in situ hybridization and FISH in pathology. Methods Mol Biol 204:343–351

    PubMed  CAS  Google Scholar 

  9. Madrid MA, Lo RW (2004) Chromogenic in situ hybridization (CISH): a novel alternative in screening archival breast cancer tissue samples for HER-2/neu status. Breast Cancer Res 6:R593–R600

    Article  PubMed  CAS  Google Scholar 

  10. Rummukainen JK, Salminen T, Lundin J et al (2001) Amplification of c-myc oncogene by chromogenic and fluorescence in situ hybridization in archival breast cancer tissue array samples. Lab Invest 811:545–1551

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Todorović-Raković, N. (2013). Detection of c-myc Amplification in Formalin-Fixed Paraffin-Embedded Tumor Tissue by Chromogenic In Situ Hybridization (CISH). In: Soucek, L., Sodir, N. (eds) The Myc Gene. Methods in Molecular Biology, vol 1012. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-429-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-429-6_17

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-428-9

  • Online ISBN: 978-1-62703-429-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics